Abstract Number: 3046 • 2015 ACR/ARHP Annual Meeting
Venous Disease-Specific Quality-of-Life Is Impaired in Patients with Vascular Behcet’s Disease
Background/Purpose: Vascular involvement is seen in up to 40% of the patients with Behcet's disease (BD), with lower extremity deep vein thrombosis (DVT) as the most…Abstract Number: 3047 • 2015 ACR/ARHP Annual Meeting
Association Between Red Blood Cell Distribution Width and Disease Activity in Behcet’s Disease
Background/Purpose: Behcet's disease (BD) is a chronic systemic inflammatory disorder characterized by recurrent oral aphtae and other systemic involvement. Red blood cell distribution width (RDW)…Abstract Number: 3048 • 2015 ACR/ARHP Annual Meeting
Work Disability over Time in Behcet’s Syndrome
Background/Purpose: Behcet’s syndrome (BS) is most active during young adulthood and may cause severe disability. We had previously observed a high frequency of work disability…Abstract Number: 3049 • 2015 ACR/ARHP Annual Meeting
Cognitive Dysfunction in Chronic Progressive Neuro-Behçet’s Disease: Comparative Study of the Brainstem and Hippocampus Region Using Brain Magnetic Resonance Imaging
Background/Purpose: Central nervous system involvement is one of the most serious complications in Behçet's disease (BD). This condition is referred to as neuro-Behçet's disease (NB)…Abstract Number: 3050 • 2015 ACR/ARHP Annual Meeting
Evaluation of Olfactory Function in Behcet’s Disease
Background/Purpose: Behçet’s disease (BD) is a chronic, relapsing type of vasculitis of unknown etiology, characterized by oral and urogenital ulcers and ocular inflammation with cutaneous,…Abstract Number: 3051 • 2015 ACR/ARHP Annual Meeting
Bronchial Artery Enlargement May Cause Recurring Hemoptysis in Behçet’s Syndrome Patients with Pulmonary Artery Involvement Despite Response to Treatment
Background/Purpose: Hemoptysis is the most frequent and feared symptom of pulmonary artery involvement (PAI) in Behçet’s syndrome (BS). Some BS patients with PAI experience recurrent…Abstract Number: 3052 • 2015 ACR/ARHP Annual Meeting
Budd-Chiari Syndrome in Behçet’s Disease:a Retrospective Multicenter Study
Background/Purpose: Budd-Chiari syndrome (BCS), or hepatic venous outflow obstruction, is a rare and serious complication of Behçet's disease (BD). The aim of this study was…Abstract Number: 3053 • 2015 ACR/ARHP Annual Meeting
Patients Treated for Behcet Syndrome in the US Have Higher Disease Activity Scores at Presentation If They Fulfill ISG Criteria and If They Are Females, However Have Less Severe Disease Overall
Background/Purpose: Diagnosis of Behcet’s syndrome (BS) is based on clinical signs and symptoms, without the use laboratory or imaging tests and the most commonly used…Abstract Number: 3054 • 2015 ACR/ARHP Annual Meeting
Takayasu’s Arteritis Associated with Behçet’s Syndrome: A Case Series of 8 Patients
Background/Purpose: Takayasu's arteritis (TA) and Behçet's syndrome (BS) are both systemic vasculitis of an unknown etiology, each with unique involvement pattern. TA affects aorta and…Abstract Number: 3055 • 2015 ACR/ARHP Annual Meeting
Evaluation of Plasma Pentraxin-3 Level in Patients with Takayasu’s Arteritis
Background/Purpose: Assessment of disease activity is one of the major difficulties in patients with TAK during follow-up. To date, no biomarker is universally accepted to…Abstract Number: 3056 • 2015 ACR/ARHP Annual Meeting
Increased Circulating Th17 Cells, Serum IL-17 and Serum IL-23 in Takayasu’s Arteritis
Background/Purpose: The immune mechanisms underlying Takayasu’s arteritis (TA) are not clear. Expanded Th17 T cell subset has been demonstrated in Giant Cell Arteritis. Gamma delta…Abstract Number: 3057 • 2015 ACR/ARHP Annual Meeting
Can We Differentiate Takayasu’s Arteritis from Atherosclerosis Using Carotid Artery Doppler Usg?
Background/Purpose: Clinicians can have difficulty in making differential diagnosis between Takayasu and atherosclerosis. This is especially true when laboratory evaluations and FDG PET are inconclusive.…Abstract Number: 3058 • 2015 ACR/ARHP Annual Meeting
NMR-Based Metabolomics Provides New Insights into the Inflammatory Processes in Takayasu Arteritis
Background/Purpose: Takayasu Arteritis (TA), a large vessel disease of unknown aetiology, is the orphan of the inflammatory vasculitides with no evidence base for therapy. It…Abstract Number: 3059 • 2015 ACR/ARHP Annual Meeting
Abnormal Body Composition in Takayasu Arteritis Patients: Role of Inflammatory Cytokines and Adipokines
Background/Purpose: Chronic inflammatory conditions including rheumatic diseases may alter body composition, especially lean and fat mass. In this process, adipokines and inflammatory cytokines appear to…Abstract Number: 3060 • 2015 ACR/ARHP Annual Meeting
The Assessment of Disease Activity in Takayasu Arteritis; Six Years Experience from a Single Center
Background/Purpose: The aim of this study is to analyze the activity parameters that affect the physicians global opinion (PGO) in TA. Methods: The data of…
ACR Meeting Abstracts